SCHEMBL13149663

SCHEMBL13149663

Cc1nc(NC(=O)n2ccnc2)sc1-c1ccc(-n2cccn2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 8/20 0.72
PIK3CA P42336 7/20 0.72
PIK3CB P42338 7/20 0.72
PIK3CG P48736 7/20 0.72
PI4KB Q9UBF8 2/20 0.61
DYRK3 O43781 1/20 0.55
MAP4K4 O95819 1/20 0.55
CLK2 P49760 1/20 0.55
DYRK1A Q13627 1/20 0.55
MINK1 Q8N4C8 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
XIAP P98170 1/20 0.43
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
ABL1 P00519 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
CLK1 P49759 1/20 0.40
TNIK Q9UKE5 5/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1885511 0.84 PIK3CD (0.47) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL2326527 0.82 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL1786172 0.81 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL12991700 0.80 PIK3CG (0.51) PIK3CDPIK3CAPIK3CBPIK3CGXIAP
SCHEMBL1882046 0.79 PIK3CA (0.43) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL1889405 0.76 PIK3CA (0.50) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL13149722 0.75 PIK3CD (0.49) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL29089052 0.74 PIK3CG (0.39) PIK3CDPIK3CAPIK3CBPIK3CGXIAP
SCHEMBL24023246 0.74 PIK3CA (0.48) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB
SCHEMBL13469237 0.74 PIK3CA (0.48) PIK3CDPIK3CAPIK3CBPIK3CGPI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799810-B2 Organic compounds NOVARTIS AG (CH) 2010-09-21 US disclosed
US-7799810-B2 Organic compounds NOVARTIS AG (CH) 2010-09-21 US disclosed
US-20100120865-A1 Organic compounds NOVARTIS AG (CH) 2010-05-13 US disclosed
US-20100120865-A1 Organic compounds NOVARTIS AG (CH) 2010-05-13 US disclosed
WO-2008000421-A2 THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NOVARTIS AG (CH) 2008-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120865-A1 Organic compounds PIK3C3, PIK3R3, PIK3R4 PIK3CD 10/4885PIK3CA 5/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.